Skip to main content

Chest Pain in Women: Evaluation and Management

  • Chapter
Controversies in Cardiology

Abstract

Despite the significant burden of ischemic heart disease (IHD) in women, the optimal evaluation and management of chest pain in this population is unclear, complicated by gender differences in presentation, etiology and disease perception as well as a relative paucity of specific, well-powered studies in this field. In contrast to male IHD, which is typically characterized by classical symptomology and demonstrable obstruction on angiography, chest pain in women is often more vague and more likely caused by an atypical etiology such as microvascular disease or endothelial dysfunction. The absence of macroscopic coronary obstruction presents a management challenge to physicians, and a large proportion of index cardiac events in women result in fatality. Evaluating chest pain is further complicated by gender discrepancies in the accuracy of diagnostic testing due to anatomical and physical variation. Furthermore, there is a distinct lack of awareness of disease severity among women and treating physicians, placing the imperative on the need for improving public education. This chapter will analyze current controversies pertaining to the evaluation and management of chest pain in women.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Treadmill angina index: 0 = no angina during exercise, 1 = non-limiting angina during exercise, 2 = exercise-limiting angina.

References

  1. American Heart Association. Heart disease and stroke statistics: 2004 Update United States 2004. Available from: http://americanheart.org/downloadable/heart/1072969766940HSStats2004Update.pdf.

  2. Mosca L, Grundy SM, Judelson D, King K, Limacher M, Oparil S, et al. Guide to preventive cardiology for women. Circulation. 1999;99(18):2480–4.

    Article  CAS  PubMed  Google Scholar 

  3. Bairey Merz CN, Shaw LJ, Reis SE, Bittner V, Kelsey SF, Olson M, et al. Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol. 2006;47(3 Suppl):S21–9. PubMed PMID: 16458167. Epub 2006/02/07. eng.

    Article  PubMed  Google Scholar 

  4. Shaw LJ, Bairey Merz CN, Pepine CJ, Reis SE, Bittner V, Kelsey SF, et al. Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) study: part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol. 2006;47(3 Suppl):S4–20.

    Article  PubMed  Google Scholar 

  5. Gulati M, Shaw LJ, Bairey Merz CN. Myocardial ischemia in women: lessons from the NHLBI WISE study. Clin Cardiol. 2012;35(3):141–8.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Kannel WB, Vokonas PS. Demographics of the prevalence, incidence, and management of coronary heart disease in the elderly and in women. Ann Epidemiol. 1992;2(1–2):5–14. PubMed PMID: 1342264. Epub 1992/01/01. eng.

    Article  CAS  PubMed  Google Scholar 

  7. Orencia A, Bailey K, Yawn BP, Kottke TE. Effect of gender on long-term outcome of angina pectoris and myocardial infarction/sudden unexpected death. JAMA. 1993;269(18):2392–7. PubMed PMID: 8479065. Epub 1993/05/12. eng.

    Article  CAS  PubMed  Google Scholar 

  8. Cowley MJ, Mullin SM, Kelsey SF, Kent KM, Gruentzig AR, Detre KM, et al. Sex differences in early and long-term results of coronary angioplasty in the NHLBI PTCA Registry. Circulation. 1985;71(1):90–7. PubMed PMID: 3155449. Epub 1985/01/01. eng.

    Article  CAS  PubMed  Google Scholar 

  9. Philpott S, Boynton PM, Feder G, Hemingway H. Gender differences in descriptions of angina symptoms and health problems immediately prior to angiography: the ACRE study. Appropriateness of Coronary Revascularisation study. Soc Sci Med. 2001;52(10):1565–75. PubMed PMID: 11314852. Epub 2001/04/21. eng.

    Article  CAS  PubMed  Google Scholar 

  10. Milner KA, Funk M, Richards S, Wilmes RM, Vaccarino V, Krumholz HM. Gender differences in symptom presentation associated with coronary heart disease. Am J Cardiol. 1999;84(4):396–9. PubMed PMID: 10468075. Epub 1999/09/01. eng.

    Article  CAS  PubMed  Google Scholar 

  11. Sullivan AK, Holdright DR, Wright CA, Sparrow JL, Cunningham D, Fox KM. Chest pain in women: clinical, investigative, and prognostic features. BMJ (Clin Res ed). 1994;308(6933):883–6.

    Article  CAS  Google Scholar 

  12. Douglas PS, Ginsburg GS. The evaluation of chest pain in women. N Engl J Med. 1996;334(20):1311–5.

    Article  CAS  PubMed  Google Scholar 

  13. Berecki-Gisolf J, Humphreyes-Reid L, Wilson A, Dobson A. Angina symptoms are associated with mortality in older women with ischemic heart disease. Circulation. 2009;120(23):2330–6. PubMed PMID: 19933930. Epub 2009/11/26. eng.

    Article  PubMed  Google Scholar 

  14. Weiner DA, Ryan TJ, McCabe CH, Kennedy JW, Schloss M, Tristani F, et al. Exercise stress testing. N Engl J Med. 1979;301(5):230–5. PubMed PMID: 449990.

    Article  CAS  PubMed  Google Scholar 

  15. Pepine CJ, Abrams J, Marks RG, Morris JJ, Scheidt SS, Handberg E. Characteristics of a contemporary population with angina pectoris. TIDES Investigators. Am J Cardiol. 1994;74(3):226–31. PubMed PMID: 8037126. Epub 1994/08/01. eng.

    Article  CAS  PubMed  Google Scholar 

  16. Khan NA, Daskalopoulou SS, Karp I, Eisenberg MJ, Pelletier R, Tsadok MA, et al. Sex differences in acute coronary syndrome symptom presentation in young patients. JAMA Intern Med. 2013;173(20):1863–71. PubMed PMID: 24043208. Epub 2013/09/18. eng.

    PubMed  Google Scholar 

  17. Talley NJ, O’Connor S. Clinical examination: a systematic guide to physical diagnosis. Sydney: Elsevier/Churchill Livingstone; 2010.

    Google Scholar 

  18. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA. 1991;265(14):1861–7.

    Article  CAS  PubMed  Google Scholar 

  19. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;316(18):1105–10. PubMed PMID: 3574358.

    Article  CAS  PubMed  Google Scholar 

  20. van der Schouw YT, van der Graaf Y, Steyerberg EW, Eijkemans JC, Banga JD. Age at menopause as a risk factor for cardiovascular mortality. Lancet. 1996;347(9003):714–8. PubMed PMID: 8602000. Epub 1996/03/16. eng.

    Article  PubMed  Google Scholar 

  21. Yu J, Johnson J, Theodoropoulos K, Mungee S, Couri M, Malasky B, et al. TCT-365 pregnancy-induced disorders identify high-risk women who benefit from cardiovascular screening: results from the Women’s Heart Health Initiative, an OB/GYN Screening Pilot Program. J Am Coll Cardiol. 2012;60(17_S):B104.

    Article  Google Scholar 

  22. Newstead J, von Dadelszen P, Magee LA. Preeclampsia and future cardiovascular risk. Expert Rev Cardiovasc Ther. 2007;5(2):283–94.

    Article  CAS  PubMed  Google Scholar 

  23. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet. 2001;357(9273):2002–6. PubMed PMID: 11438131. Epub 2001/07/05. eng.

    Article  CAS  PubMed  Google Scholar 

  24. Ahmed R, Dunford J, Mehran R, Robson S, Kunadian V. Preeclampsia and future cardiovascular risk among women: a review. J Am Coll Cardiol. 2014;63(18):1815–22. PubMed PMID: 24613324. Epub 2014/03/13. Eng.

    Article  PubMed  Google Scholar 

  25. Archambault C, Arel R, Filion KB. Gestational diabetes and risk of cardiovascular disease: a scoping review. Open Med Peer Rev Independent Open Access J. 2014;8(1):e1–9. PubMed PMID: 25009679. Pubmed Central PMCID: PMC4085089. Epub 2014/07/11. eng.

    Google Scholar 

  26. Randeva HS, Tan BK, Weickert MO, Lois K, Nestler JE, Sattar N, et al. Cardiometabolic aspects of the polycystic ovary syndrome. Endocr Rev. 2012;33(5):812–41. PubMed PMID: 22829562. Pubmed Central PMCID: PMC3461136. Epub 2012/07/26. eng.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Chasan-Taber L, Stampfer MJ. Epidemiology of oral contraceptives and cardiovascular disease. Ann Intern Med. 1998;128(6):467–77. PubMed PMID: 9499331. Epub 1998/03/14. eng.

    Article  CAS  PubMed  Google Scholar 

  28. Croft P, Hannaford PC. Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners’ oral contraception study. BMJ (Clin Res Ed). 1989;298(6667):165–8. PubMed PMID: 2493841. Pubmed Central PMCID: PMC1835478. Epub 1989/01/21. eng.

    Article  CAS  Google Scholar 

  29. Baillargeon JP, McClish DK, Essah PA, Nestler JE. Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis. J Clin Endocrinol Metab. 2005;90(7):3863–70. PubMed PMID: 15814774. Epub 2005/04/09. eng.

    Article  CAS  PubMed  Google Scholar 

  30. O’Donoghue M, Boden WE, Braunwald E, Cannon CP, Clayton TC, de Winter RJ, et al. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. JAMA. 2008;300(1):71–80. PubMed PMID: 18594042. Epub 2008/07/03. eng.

    Article  PubMed  Google Scholar 

  31. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986;111(2):383–90.

    Article  CAS  PubMed  Google Scholar 

  32. Mosca L, Banka CL, Benjamin EJ, Berra K, Bushnell C, Dolor RJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation. 2007;115(11):1481–501.

    Article  PubMed  Google Scholar 

  33. Michos ED, Vasamreddy CR, Becker DM, Yanek LR, Moy TF, Fishman EK, et al. Women with a low Framingham risk score and a family history of premature coronary heart disease have a high prevalence of subclinical coronary atherosclerosis. Am Heart J. 2005;150(6):1276–81. PubMed PMID: 16338271. Epub 2005/12/13. eng.

    Article  PubMed  Google Scholar 

  34. Spencer E, Pirie K, Stevens R, Beral V, Brown A, Liu B, et al. Diabetes and modifiable risk factors for cardiovascular disease: the prospective Million Women Study. Eur J Epidemiol. 2008;23(12):793–9. English.

    Article  PubMed  Google Scholar 

  35. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo study. JAMA. 1991;265(5):627–31.

    Article  CAS  PubMed  Google Scholar 

  36. Daly C, Clemens F, Lopez Sendon JL, Tavazzi L, Boersma E, Danchin N, et al. Gender differences in the management and clinical outcome of stable angina. Circulation. 2006;113(4):490–8.

    Article  PubMed  Google Scholar 

  37. Pope JH, Aufderheide TP, Ruthazer R, Woolard RH, Feldman JA, Beshansky JR, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med. 2000;342(16):1163–70. PubMed PMID: 10770981. Epub 2000/04/20. eng.

    Article  CAS  PubMed  Google Scholar 

  38. Varughese CJ, Pinnelas R, Yu J, Mehran R. Textbook of cardiovascular intervention. London: Springer; 2014.

    Google Scholar 

  39. Blum A, Blum N. Coronary artery disease: are men and women created equal? Gend Med. 2009;6(3):410–8. PubMed PMID: 19850237. Epub 2009/10/24. eng.

    Article  PubMed  Google Scholar 

  40. Hollander JE, Chang AM. Evaluation of chest pain in the emergency department 2013 [cited 2014 March]. Available from: http://www.uptodate.com/contents/evaluation-of-chest-pain-in-the-emergency-department?source=see_link.

  41. Diercks DB, Peacock WF, Hiestand BC, Chen AY, Pollack Jr CV, Kirk JD, et al. Frequency and consequences of recording an electrocardiogram >10 minutes after arrival in an emergency room in non-ST-segment elevation acute coronary syndromes (from the CRUSADE Initiative). Am J Cardiol. 2006;97(4):437–42. PubMed PMID: 16461033. Epub 2006/02/08. eng.

    Article  PubMed  Google Scholar 

  42. Okin PM, Roman MJ, Devereux RB, Kligfield P. Gender differences and the electrocardiogram in left ventricular hypertrophy. Hypertension. 1995;25(2):242–9.

    Article  CAS  PubMed  Google Scholar 

  43. O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61(4):e78–140.

    Article  PubMed  Google Scholar 

  44. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Circulation. 2012;126(16):2020–35. PubMed PMID: 22923432. Epub 2012/08/28. eng.

    Article  PubMed  Google Scholar 

  45. Lagerqvist B, Säfström K, Ståhle E, Wallentin L, Swahn E. Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? J Am Coll Cardiol. 2001;38(1):41–8.

    Article  CAS  PubMed  Google Scholar 

  46. Wiviott SD, Cannon CP, Morrow DA, Murphy SA, Gibson CM, McCabe CH, et al. Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction 18) substudy. Circulation. 2004;109(5):580–6. PubMed PMID: 14769678. Epub 2004/02/11. eng.

    Article  CAS  PubMed  Google Scholar 

  47. Agarwal M, Mehta PK, Bairey Merz CN. Nonacute coronary syndrome anginal chest pain. Med Clin North Am. 2010;94(2):201–16. PubMed PMID: 20380951. Pubmed Central PMCID: PMC2876979. Epub 2010/04/13. eng.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  48. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347(20):1557–65. PubMed PMID: 12432042.

    Article  CAS  PubMed  Google Scholar 

  49. Members C, Gibbons RJ, Balady GJ, Timothy Bricker J, Chaitman BR, Fletcher GF, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation. 2002;106(14):1883–92.

    Article  Google Scholar 

  50. Kwok Y, Kim C, Grady D, et al. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol. 1999;83:660–6.

    Article  CAS  PubMed  Google Scholar 

  51. Shaw LJTS, Rosen S, Mieres JH. Evaluation of suspected ischemic heart disease in symptomatic women. Can J Cardiol. 2014;30(7):729–37.

    Article  PubMed  Google Scholar 

  52. Stangl V, Witzel V, Baumann G, Stangl K. Current diagnostic concepts to detect coronary artery disease in women. Eur Heart J. 2008;29(6):707–17. PubMed PMID: 18272503. Epub 2008/02/15. eng.

    Article  PubMed  Google Scholar 

  53. Mark DB, Hlatky MA, Harrell Jr FE, Lee KL, Califf RM, Pryor DB. Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med. 1987;106:793–800.

    Article  CAS  PubMed  Google Scholar 

  54. Gulati M, Black HR, Shaw LJ, Arnsdorf MF, Merz CNB, Lauer MS, Marwick TH, Pandey DK, Wicklund RH, Thisted RA. The prognostic value of a nomogram for exercise capacity in women. N Engl J Med. 2005;353(5):468–75.

    Article  CAS  PubMed  Google Scholar 

  55. Gibbons RJ. Abnormal heart-rate recovery after exercise. Lancet. 2002;359(9317):1536–7.

    Article  PubMed  Google Scholar 

  56. Mieres JH, Shaw LJ, Arai A, Budoff MJ, Flamm SD, Hundley WG, et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention. Am Heart Assoc Circ. 2005;111(5):682–96. PubMed PMID: 15687114. Epub 2005/02/03. eng.

    Google Scholar 

  57. Williams MJ, Marwick TH, O’Gorman D, Foale RA. Comparison of exercise echocardiography with an exercise score to diagnose coronary artery disease in women. Am J Cardiol. 1994;74(5):435–8. PubMed PMID: 8059721. Epub 1994/09/01. eng.

    Article  CAS  PubMed  Google Scholar 

  58. Douglas PS. Is noninvasive testing for coronary artery disease accurate? Circulation. 1997;95(2):299–302.

    Article  CAS  PubMed  Google Scholar 

  59. Grundy SM, Pasternak R, Greenland P, Smith S, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999;100(13):1481–92.

    Article  CAS  PubMed  Google Scholar 

  60. Mieres JH, Shaw LJ, Hendel RC, Miller DD, Bonow RO, Berman DS, Heller GV, Mieres JH, Bairey-Merz CN, Berman DS, Bonow RO, Cacciabaudo JM, Heller GV, Hendel RC, Kiess MC, Miller DD, Polk DM, Shaw LJ, Smanio PE, Walsh MN, Writing Group on Perfusion Imaging in Women. American Society of Nuclear Cardiology consensus statement: Task Force on Women and Coronary Artery Disease—the role of myocardial perfusion imaging in the clinical evaluation of coronary artery disease in women. J Nucl Cardiol. 2003;10:95–101.

    Article  PubMed  Google Scholar 

  61. Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol. 2004;11(2):171–85. PubMed PMID: 15052249. Epub 2004/03/31. eng.

    Article  Google Scholar 

  62. Nurkalem Z, Sahin S, Uslu N, Emre A, Alper AT, Gorgulu S, et al. Predicting breast attenuation in patients undergoing myocardial perfusion scintigraphy: a digital x-ray study. J Digit Imaging. 2008;21(4):446–51. PubMed PMID: 17703339. Pubmed Central PMCID: PMC3043850. Epub 2007/08/19. eng.

    Article  PubMed Central  PubMed  Google Scholar 

  63. Mieres JH, Shaw LJ, Hendel RC, Miller DD, Bonow RO, Berman DS, et al. American Society of Nuclear Cardiology consensus statement: Task Force on Women and Coronary Artery Disease–the role of myocardial perfusion imaging in the clinical evaluation of coronary artery disease in women [correction]. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol. 2003;10(1):95–101. PubMed PMID: 12569338. Epub 2003/02/06. eng.

    Article  Google Scholar 

  64. Ajlan AM, Heilbron BG, Leipsic J. Coronary computed tomography angiography for stable angina: past, present, and future. Can J Cardiol. 2013;29(3):266–74.

    Article  PubMed  Google Scholar 

  65. Min JK, Shaw LJ, Berman DS. The present state of coronary computed tomography angiography. A process in evolution. J Am Coll Cardiol. 2010;55(10):957–65.

    Article  PubMed  Google Scholar 

  66. Min JK, Dunning A, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ, et al. Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings: Results from the international multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: an International Multicenter Registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol. 2011;58(8):849–60.

    Article  PubMed  Google Scholar 

  67. Litwin SE, Priester TC. Diagnosing coronary artery disease in women: an update on cardiac imaging modalities. Obstet Gynecol. 2010;115(1):156–69. PubMed PMID: 20027049. Epub 2009/12/23. eng.

    Article  PubMed  Google Scholar 

  68. Wenger NK. Coronary heart disease in women. Springer; 2009. p. 337–69.

    Google Scholar 

  69. Gan SC, Beaver SK, Houck PM, MacLehose RF, Lawson HW, Chan L. Treatment of acute myocardial infarction and 30-day mortality among women and men. N Engl J Med. 2000;343(1):8–15.

    Google Scholar 

  70. Scirica BM, Moliterno DJ, Every NR, Anderson HV, Aguirre FV, Granger CB, et al. Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE Investigators. Am J Cardiol. 1999;84(10):1145–50. PubMed PMID: 10569321. Epub 1999/11/24. eng.

    Article  CAS  PubMed  Google Scholar 

  71. Jespersen L, Hvelplund A, Abildstrøm SZ, Pedersen F, Galatius S, Madsen JK, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2012;33(6):734–44.

    Article  PubMed  Google Scholar 

  72. Shaw LJ, Merz CNB, Pepine CJ, Reis SE, Bittner V, Kip KE, et al. The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation. Circulation. 2006;114(9):894–904.

    Article  PubMed  Google Scholar 

  73. Von Mering GO, Arant CB, Wessel TR, McGorray SP, Bairey Merz CN, Sharaf BL, et al. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation. 2004;109(6):722–5.

    Article  Google Scholar 

  74. Pepine CJ, Anderson RD, Sharaf BL, Reis SE, Smith KM, Handberg EM, et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia. Results from the National Heart, Lung and Blood Institute WISE (Women’s Ischemia Syndrome Evaluation) study. J Am Coll Cardiol. 2010;55(25):2825–32.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  75. Halcox JPJ, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation. 2002;106(6):653–8.

    Article  PubMed  Google Scholar 

  76. Bairey Merz CN, Pepine CJ. Syndrome X and microvascular coronary dysfunction. Circulation. 2011;124(13):1477–80.

    Article  PubMed  Google Scholar 

  77. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non–ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation. 2007;116(7):803–77.

    Article  Google Scholar 

  78. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction. J Am Coll Cardiol. 2008;51(2):210–47.

    Article  PubMed  Google Scholar 

  79. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124(23):2574–609.

    Article  PubMed  Google Scholar 

  80. Anderson ML, Peterson ED, Brennan JM, Rao SV, Dai D, Anstrom KJ, et al. Short- and long-term outcomes of coronary stenting in women versus men: results from the National Cardiovascular Data Registry Centers for Medicare & Medicaid services cohort. Circulation. 2012;126(18):2190–9. PubMed PMID: 22988009. Epub 2012/09/19. eng.

    Article  PubMed  Google Scholar 

  81. Angeja BG, Gibson CM, Chin R, Frederick PD, Every NR, Ross AM, et al. Predictors of door-to-balloon delay in primary angioplasty. Am J Cardiol. 2002;89(10):1156–61.

    Article  PubMed  Google Scholar 

  82. Ayanian JZ, Epstein AM. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med. 1991;325(4):221–5. PubMed PMID: 2057022. Epub 1991/07/25. eng.

    Article  CAS  PubMed  Google Scholar 

  83. Rathore SS, Wang Y, Radford MJ, Ordin DL, Krumholz HM. Sex differences in cardiac catheterization after acute myocardial infarction: the role of procedure appropriateness. Ann Intern Med. 2002;137(6):487–93. PubMed PMID: 12230349. Epub 2002/09/17. eng.

    Article  PubMed  Google Scholar 

  84. Yu J, Mehran R, Grinfeld L, Xu K, Nikolsky E, Brodie BR, et al. Sex-based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: three year results from the HORIZONS-AMI trial. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 2015;85(3):359–68. PubMed PMID: 25115966. Epub 2014/08/15. Eng.

    Article  Google Scholar 

  85. Lansky AJ, Pietras C, Costa RA, Tsuchiya Y, Brodie BR, Cox DA, et al. Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Circulation. 2005;111(13):1611–8. PubMed PMID: 15811868. Epub 2005/04/07. eng.

    Article  CAS  PubMed  Google Scholar 

  86. Lansky AJ, Hochman JS, Ward PA, Mintz GS, Fabunmi R, Berger PB, et al. Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association. Circulation. 2005;111(7):940–53.

    Article  PubMed  Google Scholar 

  87. Lansky AJ, Costa RA, Mooney M, Midei MG, Lui HK, Strickland W, et al. Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease. J Am Coll Cardiol. 2005;45(8):1180–5. PubMed PMID: 15837246. Epub 2005/04/20. eng.

    Article  CAS  PubMed  Google Scholar 

  88. Lansky AJ. Outcomes of percutaneous and surgical revascularization in women. Prog Cardiovasc Dis. 2004;46(4):305–19.

    Article  PubMed  Google Scholar 

  89. Stefanini GG, Baber U, Windecker S, Morice MC, Sartori S, Leon MB, et al. Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials. Lancet. 2013;382(9908):1879–88. PubMed PMID: 24007976. Epub 2013/09/07. eng.

    Article  CAS  PubMed  Google Scholar 

  90. Mehran R, Pocock SJ, Nikolsky E, Clayton T, Dangas GD, Kirtane AJ, et al. A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol. 2010;55(23):2556–66.

    Article  PubMed  Google Scholar 

  91. Boersma E, Harrington RA, Moliterno DJ, White H, Theroux P, Van de Werf F, et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet. 2002;359(9302):189–98. PubMed PMID: 11812552. Epub 2002/01/29. eng.

    Article  CAS  PubMed  Google Scholar 

  92. Kelsey SF, James M, Holubkov AL, Holubkov R, Cowley MJ, Detre KM. Results of percutaneous transluminal coronary angioplasty in women. 1985–1986 National Heart, Lung, and Blood Institute’s Coronary Angioplasty Registry. Circulation. 1993;87(3):720–7.

    Article  CAS  PubMed  Google Scholar 

  93. Lincoff AM, Tcheng JE, Califf RM, Bass T, Popma JJ, Teirstein PS, et al. Standard versus Low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. Am J Cardiol. 1997;79(3):286–91.

    Article  CAS  PubMed  Google Scholar 

  94. Mandak JS, Blankenship JC, Gardner LH, Berkowitz SD, Aguirre FV, Sigmon KN, et al. Modifiable risk factors for vascular access site complications in the IMPACT II trial of angioplasty with versus without eptifibatide. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis. J Am Coll Cardiol. 1998;31(7):1518–24. PubMed PMID: 9626829. Epub 1998/06/17. eng.

    Article  CAS  PubMed  Google Scholar 

  95. Bernat I, Horak D, Stasek J, Mates M, Pesek J, Ostadal P, et al. ST-segment elevation myocardial infarction treated by radial or femoral approach in a multicenter randomized clinical trial: the STEMI-RADIAL trial. J Am Coll Cardiol. 2014;63(10):964–72. PubMed PMID: 24211309. Epub 2013/11/12. eng.

    Article  PubMed  Google Scholar 

  96. Rao SV, Hess CN, Barham B, Aberle LH, Anstrom KJ, Patel TB, et al. A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial. JACC Cardiovasc Interv. 2014;7(8):857–67. PubMed PMID: 25147030. Epub 2014/08/26. eng.

    Article  PubMed  Google Scholar 

  97. Brown PP, Mack MJ, Simon AW, Battaglia S, Tarkington L, Horner S, et al. Outcomes experience with off-pump coronary artery bypass surgery in women. Ann Thorac Surg. 2002;74(6):2113–9; discussion 20. PubMed PMID: 12643404. Epub 2003/03/20. eng.

    Article  PubMed  Google Scholar 

  98. Blankstein R, Ward RP, Arnsdorf M, Jones B, Lou Y-B, Pine M. Female gender is an independent predictor of operative mortality after coronary artery bypass graft surgery: contemporary analysis of 31 Midwestern Hospitals. Circulation. 2005;112(9 Suppl):I323–7.

    PubMed  Google Scholar 

  99. Humphries KH, Gao M, Pu A, Lichtenstein S, Thompson CR. Significant improvement in short-term mortality in women undergoing coronary artery bypass surgery (1991 to 2004). J Am Coll Cardiol. 2007;49(14):1552–8. PubMed PMID: 17418294. Epub 2007/04/10. eng.

    Article  PubMed  Google Scholar 

  100. Boersma E, Harrington RA, Moliterno DJ, White H, Simoons ML. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Lancet. 2002;360(9329):342–3. PubMed PMID: 12147403. Epub 2002/07/31. eng.

    Article  PubMed  Google Scholar 

  101. Fernandes LS, Tcheng JE, O’Shea JC, Weiner B, Lorenz TJ, Pacchiana C, et al. Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention? Lessons from the ESPRIT study. J Am Coll Cardiol. 2002;40(6):1085–91. PubMed PMID: 12354432. Epub 2002/10/02. eng.

    Article  PubMed  Google Scholar 

  102. Ebbinghaus J, Maier B, Schoeller R, Schuhlen H, Theres H, Behrens S. Routine early invasive strategy and in-hospital mortality in women with non-ST-elevation myocardial infarction: results from the Berlin Myocardial Infarction Registry (BMIR). Int J Cardiol. 2012;158(1):78–82. PubMed PMID: 21277642. Epub 2011/02/01. eng.

    Article  PubMed  Google Scholar 

  103. Alexander KP, Chen AY, Roe MT, Newby LK, Gibson CM, Allen-LaPointe NM, et al. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA. 2005;294(24):3108–16. PubMed PMID: 16380591. Epub 2005/12/29. eng.

    Article  CAS  PubMed  Google Scholar 

  104. Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (Sapat) Group. Lancet. 1992;340(8833):1421–5. PubMed PMID: 1360557. Epub 1992/12/12. eng.

    Article  CAS  PubMed  Google Scholar 

  105. Becker DM, Segal J, Vaidya D, Yanek LR, Herrera-Galeano JE, Bray PF, et al. Sex differences in platelet reactivity and response to low-dose aspirin therapy. JAMA. 2006;295(12):1420–7. PubMed PMID: 16551714. Epub 2006/03/23. eng.

    Article  CAS  PubMed  Google Scholar 

  106. Xhyheri B, Bugiardini R. Diagnosis and treatment of heart disease: are women different from men? Prog Cardiovasc Dis. 2010;53(3):227–36. PubMed PMID: 21130920. Epub 2010/12/07. eng.

    Article  PubMed  Google Scholar 

  107. Bugiardini R, Bairey Merz CN. Angina with “normal” coronary arteries: a changing philosophy. JAMA. 2005;293(4):477–84. PubMed PMID: 15671433. Epub 2005/01/27. eng.

    Article  CAS  PubMed  Google Scholar 

  108. Sadowski M, Gasior M, Gierlotka M, Janion M, Polonski L. Gender-related differences in mortality after ST-segment elevation myocardial infarction: a large multicentre national registry. EuroIntervention J EuroPCR Collaboration Working Group Interv Cardiol Eur Soc Cardiol. 2011;6(9):1068–72. PubMed PMID: 21518678. Epub 2011/04/27. eng.

    Article  Google Scholar 

  109. Allen JK, Scott LB, Stewart KJ, Young DR. Disparities in women’s referral to and enrollment in outpatient cardiac rehabilitation. J Gen Intern Med. 2004;19(7):747–53. PubMed PMID: 15209588. Pubmed Central PMCID: PMC1492482. Epub 2004/06/24. eng.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Disclosures

All authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Roxana Mehran MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Warren, J., Yu, J., Grinfeld, L.R., Mehran, R. (2015). Chest Pain in Women: Evaluation and Management. In: Ambrose, J., Rodríguez, A. (eds) Controversies in Cardiology. Springer, Cham. https://doi.org/10.1007/978-3-319-20415-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-20415-4_9

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-20414-7

  • Online ISBN: 978-3-319-20415-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics